Evidence map›Paper›PMID 30605489›Full record

ArticlePloS one2019

Increased von Willebrand factor parameters in children with febrile seizures.

Astrid Pechmann, Sven Wellmann, Benjamin Stoecklin, Marcus Krüger, Barbara Zieger

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05008458 unknown statusnot on this mapstarted 2021, after this paper: background citation

Value of Von Willebrand Factor and Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital

TypeobservationalSponsorSohag UniversityRan2021 to 2022Enrolled90ConditionsFebrile SeizureArmsvon willebrand factor and copeptin
NCT05215366 unknown statusnot on this mapstarted 2022, after this paper: background citation

Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital

TypeobservationalSponsorSohag UniversityRan2022 to 2022Enrolled90ConditionsFebrile SeizureArmscopeptin biomarker in children with febrile seizures
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Astrid PechmannDepartment of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0001-9579-2343
Sven WellmannDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Benjamin StoecklinDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Marcus KrügerDepartment of Neonatology, Municipal Hospital Munich Campus Harlaching and Schwabing, Germany.
Barbara ZiegerDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
University of Basel · CHUniversity of Freiburg · DEMünchen Klinik Harlaching · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary blood coagulation and wound sealing are orchestrated by von Willebrand factor (VWF), a large multimeric glycoprotein. Upon release of arginine vasopressin (AVP), VWF containing high molecular weight multimers is secreted. By measuring copeptin, the C-terminal part of the AVP prohormone, we recently found strongly increased AVP levels in children with febrile seizures (FS) as compared to children with fever but without seizures. It is unknown if increased AVP levels in FS are of any biological function. Therefore, our a priori hypothesis was that children with FS have increased VWF parameters in parallel with higher AVP levels.

methodsWe conducted a prospective, cross-sectional study of children aged between 6 months and 5 years. Children that presented at our emergency department with fever or a recent FS (within four hours) were evaluated to be included to the study. We measured serum copeptin and VWF parameters, including analyses of VWF:Antigen (WVF:Ag), VWF:collagen binding activity (VWF:CB) and VWF multimers in children with FS, febrile infections without seizures and additionally, in a non-febrile control group.

resultsWe included 54 children in our study, 30 with FS, 10 in the febrile control group, and 14 in the non-febrile control group. Serum copeptin levels were significantly higher in children with FS (median [IQR] 24.73 pmol/l [13.65-68.65]) compared to the febrile control group (5.66 pmol/l [4.15-8.07], p = 0.002) and the non-febrile control group (4.78 pmol/l [3.33-5.3], p<0.001). VWF:CB levels were also significantly higher in children with FS (VWF:CB 2.29 U/ml [1.88-2.97]) as compared to the febrile (VWF:CB 1.41 U/ml [1.27-1.93], p = 0.048) and the non-febrile control group (VWF:CB 1.15 U/ml [0.98-1.21], p<0.001). VWF:Ag tended to be higher in children with FS compared to both control groups. Multivariate regression analysis revealed FS and copeptin as major determinants of VWF:CB.

conclusionsOur results suggest that increased secretion of AVP in children with FS is associated with higher plasma levels of VWF parameters. Especially VWF:CB may serve as additional biomarker in the diagnosis of FS.

Indexed as

BiomarkersChild, PreschoolCross-Sectional StudiesFemaleFeverGlycopeptidesHumansInfantMaleNeurophysinsProspective StudiesProtein PrecursorsSeizures, FebrileVasopressinsvon Willebrand Diseasesvon Willebrand FactorAVP protein, humanBiomarkerscopeptinsGlycopeptidesNeurophysinsProtein PrecursorsVasopressinsvon Willebrand Factor

Identifiers

PMID30605489
PMCPMC6317815
OpenAlexW2907373713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.